PDS Biotechnology Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

PDS Biotechnology Stock Summary

PDS Biotechnology competes with Mereo BioPharma, Terns Pharmaceuticals, Inozyme Pharma, Hookipa Pharma, and Enveric Biosciences. PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. Pds Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.

PDS Biotechnology Key Financial Ratios

PDS Biotechnology Key Balance Sheet Accounts

PDS Biotechnology Key Income Statement Accounts

PDS Biotechnology Key Cash Accounts

PDS Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining PDS Biotechnology's current stock value. Our valuation model uses many indicators to compare PDS Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PDS Biotechnology competition to find correlations between indicators driving PDS Biotechnology's intrinsic value. More Info.PDS Biotechnology Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, PDS Biotechnology's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PDS Biotechnology's earnings, one of the primary drivers of an investment's value.

PDS Biotechnology Corp Systematic Risk

Today, most investors in PDS Biotechnology Stock are looking for potential investment opportunities by analyzing not only static indicators but also various PDS Biotechnology's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of PDS Biotechnology growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of PDS Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PDS Biotechnology Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of PDS Biotechnology Corp based on widely used predictive technical indicators. In general, we focus on analyzing PDS Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PDS Biotechnology's daily price indicators and compare them against related drivers.

When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.